echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Do a good job in the "three balances" of the "dual-channel" management of national talks drugs

    Do a good job in the "three balances" of the "dual-channel" management of national talks drugs

    • Last Update: 2021-06-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Wen | Caozhuang, Associate Researcher, National Medical Security Research Institute, Capital Medical University

    Recently, the National Medical Insurance Administration and the National Health Commission issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for Drugs in National Medical Insurance Negotiations" (hereinafter referred to as the "Guiding Opinions") to promote the "dual-channel" management of Chinese medicines at the national level.


    This reform is an innovation in the management mechanism.


    1.


    1.


    The prerequisite for implementing "dual channels" is to implement classified management of negotiated drugs.


    To achieve a good balance between the drugs in the catalog, the provincial medical insurance department needs to determine uniform standards, make procedures open, play the role of experts, and conduct scientific selection.


    2.


    2.


    This separate payment model is similar to the one-line drug payment policy in Sichuan Province.


    When exploring the establishment of such a separate drug security mechanism, provinces should pay attention to the balance of treatment policies: that is, the proportion of drug reimbursements for the implementation of the separate payment policy and other drugs; the treatment policy enjoyed by the insured persons using such drugs is different from the original treatment policy.


    3.


    3.


    The first is to guide and give full play to the role of market players.


    The above "three balances" test the wisdom and ability of medical insurance administrators, and also reflect the difficulty of mechanism innovation.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.